Effect of various glucagon/insulin molar ratios on blood ketone body levels in rats by use of osmotic minipumps

Diabetes Research and Clinical Practice

Volumn 34, Issue 1, 1996, Pages 1-6

  Ubukata, Eiichi ^a   Mokuda, Osamu ^a   Sakamoto, Yoshikazu ^a   Shimizu, Naokata ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

glucagon insulin molar ratio; ketone body; osmotic minipump

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; FATTY ACID; GLUCAGON; GLUCOSE; HUMAN INSULIN; INSULIN; KETONE BODY; OCTREOTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OSMOTIC MINIPUMP; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; ANIMALS; DRUG INTERACTIONS; FATTY ACIDS, NONESTERIFIED; GLUCAGON; HYDROXYBUTYRATES; INFUSIONS, PARENTERAL; INSULIN; KETONE BODIES; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0030248932     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)01325-3     Document Type: Article

References (24)

1. [1] Miles, J.M. and Gerich, J.E. (1983) Glucose and ketone body kinetics in diabetic ketoacidosis. Clin. Endocrinol. Metab. 12, 303-319.
2. [2] Bewsher, P.D. and Ashmore, J. (1966) Ketogenic and lipolytic effects of glucagon on liver. Biochem. Biophys. Res. 24, 431-436.
3. [3] Regen, D.M. and Terrell, E.B. (1968) Effects of glucagon and fasting on acetate metabolism in perfused rat liver. Biochim. Biophys. Acta 170, 95-111.
4. [4] McGarry, J.D., Wright, P.M. and Foster, D.W. (1975) Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. J. Clin. Invest. 55, 1202-1209.
5. [5] McGarry, J.D. and Foster, D.W. (1977) Hormonal control of ketogenesis. Arch. Intern. Med. 137, 495-501.
6. [6] Ubukata, E. (1990) Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum c-peptide immunoreactivity and free insulin. Ann. Nutr. Metab. 34, 333-342.
7. [7] Owen, O.E., Caprio, S., Reichard, G.A., Mozzoli, M.A., Boden, G. and Owen, R.S. (1983) Ketosis of starvation: a revisit and new perspectives. Clin. Endocrinol. Metab. 12, 359-379.
8. [8] Barnes, A.J., Bloom, S.R., Alberti, K.G.M.M., Smythe, P., Alford, F.P. and Chisholm, D.J. (1977) Ketoacidosis in pancreatectomized man. N. Engl. J. Med. 296, 1250-1253.
9. [9] Pless, J., Bauer, W., Briner, U. et al. (1986) Chemistry and pharmacology of SMS 201-995, a long acting octapeptide analogue of somatostatin. Scand. J. Gastroenterol. 21, 54-64.
10. [10] Markussen, J., Damgaard, U., Pingel, M., Snel, L., Sørensen, A.R. and Sørensen, E. (1983) Human insulin (NOVO): Chemistry and characteristics. Diabetes Care 6, 4-8.
11. [11] Sugasc, T., Nonaka, K., Yoshida, T. et al. (1976) Comparison of the changes in plasma human growth hormone (HGH) and immuno-reactive glucagon (IRG) after intravenous and subcutaneous injection of glucagon. Endocrinol. Jpn. 23, 187-193.
12. [12] Harano, Y., Kosugi, K., Hyosu, T., Uno, S., Ichikawa, Y. and Shigeta, Y. (1983) Sensitive and simplified method for the differential determination of serum levels of ketone bodies. Clin. Chim. Acta 134, 327-336.
13. [13] Unger, R.H. (1971) Glucagon and the insulin:glucagon ratio in diabetes and other catabolic illnesses. Diabetes 20, 834-838.
14. [14] Johnston, D.G. and Alberti, K.G.M.M. (1982) Hormonal control of ketone body metabolism in the normal and diabetic state. Clin. Endocrinol. Metab. 11, 329-361.
15. [15] Parrilla, R., Goodman, M.H. and Toews, C.J. (1974) Effect of glucagon:insulin ratios on hepatic metabolism. Diabetes 23, 725-731.
16. [16] Müller, W.A., Faloona, G.R. and Unger, R.H. (1973) Hyperglucagonemia in diabetic ketoacidosis, its prevalence and significance. Am. J. Med. 54, 52-57.
17. [17] Keller, U., Lustenberger, M.. Müller-Brand, J., Gerber, P.P.G. and Stauffacher, W. (1989) Human ketone body production and utilization studied using tracer techniques: Regulation by free fatty acids, insulin, catecholamines, and thyroid hormones. Diabetes Metab. Rev. 5, 285-298.
18. [18] Bieberdorf, F.A., Chernick, S.S. and Scow, R.O. (1970) Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat. J. Clin. Invest. 49, 1685-1693.
19. [19] Robinson, A. M. and Williamson, D.H. (1980) Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60, 143-187.
20. [20] Werk, E.E. and Knowles, H.C. (1961) The blood ketone and plasma free fatty acid concentration in diabetic and normal subjects. Diabetes 10, 22-32.
21. [21] Bieberdorf, F.A., Chernick, S.S. and Scow, R.O. (1970) Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat. J. Clin. Invest. 49, 1685-1693.
22. [22] Ubukata, E., Mokuda, O., Sakamoto, Y. and Shimizu, N. (1992) Effect of FFA on ketone body production in rat's liver perfusion system. Horm. Metab. Res. 24, 134-135.
23. [23] Woods, S.C., Lotter, B.C., McKay, L.D. and Porte, D. (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505.
24. [24] Inokuchi, A., Oomura, Y. and Nishimura, H. (1984) Effect of intracerebroventricularly infused glucagon on feeding behavior. Physiol. Behav. 33, 397-400.